|
⚲
|
| Frazier Life Sciences Management LP
✚
|
|
|---|---|
| CRD # | 317522 |
| SEC # | 801-122904 |
| CIK # | |
| AUM | $7.0 B (2026-03-31) |
| Employees | 64 (73% Investors, 0% Brokers) |
| Phone | 650-325-5156 |
| Address | 1001 Page Mill Road Palo Alto, CA 94304 |
| Source | [IAPD] [Website] [LinkedIn] |
| Total AUM ($B) |
|---|
| Type | Form D Funds | Date | Sold ($M) | AUM ($M) |
|---|---|---|---|---|
| VC | Frazier Life Sciences XII LP | [2025-03-31] | 0.0 | 1,350.6 |
| HF | Frazier Life Sciences Public Overage Fund LP | [2023-03-31] | 243.1 | 362.2 |
| HF | Frazier Life Sciences Public Fund LP | [2022-03-31] | 0.0 | 2,868.0 |
| VC | Frazier Life Sciences Xi LP | [2022-03-31] | 960.0 | 1,107.8 |
| PE | Frazier Life Sciences X LP | [2020-03-30] | 0.0 | 781.2 |
| VC | Frazier Life Sciences IX LP | [2018-03-30] | 418.9 | 596.5 |
| VC | Frazier Life Sciences VIII LP | [2016-03-29] | 262.0 | 260.2 |
| AUM Breakdown | Accounts | AUM ($B) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 8 | 7.0 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 8 | 7.0 |
| By Discretionary | ||
| Discretionary | 8 | 7.0 |
| Non-Discretionary | 0 | 0.0 |
| Total | 8 | 7.0 |
| By Non-United States Persons | ||
| Non-United States Persons | 0.0 | |
| United States Persons | 7.0 | |
| Total | 8 | 7.0 |
| Form D Directors | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|
| Patrick Heron | 58 | ||
| James Topper | 58 | ||
| Nader Naini | 43 | ||
| Nathan Every | 41 | ||
| Steve Bailey | 23 | ||
| Alan Frazier | 16 | ||
| Daniel Estes | 10 | ||
| Frazier Management LLC | 6 | ||
| Fhmlsp Overage LLC | 2 | ||
| Fhmlsp Overage LP | 2 | ||
| FHM Life Sciences VIII LLC | 1 | ||
| FHM Life Sciences VIII LP | 1 | ||
| Fhmls IX LLC | 1 | ||
| Fhmls IX LP | 1 |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Arbour Lane Capital Management LP
✚
|
CT | 7.3 |
|
Peak Rock Capital LLC
✚
|
TX | 7.3 |
|
Caspian Capital LP
✚
|
NY | 7.0 |
|
Tilden Park Capital Management LP
✚
|
NY | 6.8 |
|
First Sentier Investors Australia RE Ltd
✚
|
6.8 | |
|
Atairos Management LP
✚
|
PA | 6.8 |
|
Lead Edge Capital Management LLC
✚
|
NY | 6.8 |
|
Discovery Capital Management LLC
✚
|
CT | 6.7 |
|
BC Partners Advisors LP
✚
|
NY | 6.7 |
|
NXT Capital Investment Advisers LLC
✚
|
IL | 6.6 |